Lance Henagan, NP
Acute Care · New Orleans, LANPI 1326422924
Payments from drug & device makers
Across 29 payments — averaging $18.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$183
- Merck$93
- Edwards Lifesciences$48
- Kestra Medical Technology Services, Inc.$39
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$37
- Abiomed$31
- plus $105 from 6 others
What the payments were for
- Food & beverage$536100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 10 | $183 |
| Merck | 5 | $93 |
| Edwards Lifesciences | 1 | $48 |
| Kestra Medical Technology Services, Inc. | 1 | $39 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $37 |
| Abiomed | 2 | $31 |
| Bard Peripheral Vascular, Inc. | 1 | $20 |
| Novo Nordisk | 1 | $18 |
| Amgen | 1 | $18 |
| Pfizer | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Bayer | 1 | $14 |
How this compares
$536 in reported general payments places this provider in the 50th percentile of 248 acute care providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 67 | $754 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 111 | $617 |
| Gabapentin | 19 | $122 |
| Methylprednisolone | 18 | $94 |
| Celecoxib | 12 | $80 |
| Cyclobenzaprine Hcl | 19 | $64 |
| Meloxicam | 18 | $63 |
| Tramadol Hcl | 28 | $51 |
Paid to pharmacies, not to this prescriber.
Other acute care in New Orleans
- Charles JarreauNew Orleans$40K
- Anita RichardNew Orleans$7K
- Candita ThompsonNew Orleans$2K
- Erica LoveNew Orleans$2K
- Annie StadstadNew Orleans$2K
- Jennifer FlemingNew Orleans$2K
- Travis KingNew Orleans$2K
- Precious HodgesLafayette$70K
- Brinton FegleyShreveport$61K
- Jeremy DavisShreveport$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.